<code id='F96F62FB21'></code><style id='F96F62FB21'></style>
    • <acronym id='F96F62FB21'></acronym>
      <center id='F96F62FB21'><center id='F96F62FB21'><tfoot id='F96F62FB21'></tfoot></center><abbr id='F96F62FB21'><dir id='F96F62FB21'><tfoot id='F96F62FB21'></tfoot><noframes id='F96F62FB21'>

    • <optgroup id='F96F62FB21'><strike id='F96F62FB21'><sup id='F96F62FB21'></sup></strike><code id='F96F62FB21'></code></optgroup>
        1. <b id='F96F62FB21'><label id='F96F62FB21'><select id='F96F62FB21'><dt id='F96F62FB21'><span id='F96F62FB21'></span></dt></select></label></b><u id='F96F62FB21'></u>
          <i id='F96F62FB21'><strike id='F96F62FB21'><tt id='F96F62FB21'><pre id='F96F62FB21'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:19
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

          PeterMarks,theFDA'stopregulatorofgenetherapies(right),speakswithSTAT'sAdamFeuersteininSanFrancisco.S

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          DeSantis can now import cheaper drugs. But will Biden get credit?

          FloridagovernorandGOPpresidentialcandidateRonDeSantismadedrugimportationapolicypriority.CharlieNeibe